Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Veeva Systems

DB:VEE
Snowflake Description

Excellent balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
VEE
DB
$23B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The last earnings update was 8 days ago. More info.


Add to Portfolio Compare Print
VEE Share Price and Events
7 Day Returns
0%
DB:VEE
16.8%
DE Healthcare Services
2.1%
DE Market
1 Year Returns
23.9%
DB:VEE
15.8%
DE Healthcare Services
-16.6%
DE Market
VEE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Veeva Systems (VEE) 0% 13.4% 13.9% 23.9% 200.3% 471.8%
DE Healthcare Services 16.8% 4.4% -1.9% 15.8% 50.3% 117%
DE Market 2.1% -12.6% -22.9% -16.6% -21.9% -27.8%
1 Year Return vs Industry and Market
  • VEE outperformed the Healthcare Services industry which returned 15.8% over the past year.
  • VEE outperformed the Market in Germany which returned -16.6% over the past year.
Price Volatility
VEE
Industry
5yr Volatility vs Market
Related Companies

VEE Value

 Is Veeva Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Veeva Systems to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Veeva Systems.

DB:VEE Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 17 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 4.3%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:VEE
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.79
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.794 (1 + (1- 21%) (0.23%))
0.863
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.86
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.863 * 5.44%)
4.3%

Discounted Cash Flow Calculation for DB:VEE using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Veeva Systems is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:VEE DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 4.3%)
2020 390.83 Analyst x9 374.70
2021 480.44 Analyst x9 441.61
2022 588.61 Analyst x9 518.72
2023 783.62 Analyst x2 662.08
2024 896.12 Est @ 14.36% 725.90
2025 985.14 Est @ 9.93% 765.09
2026 1,052.48 Est @ 6.84% 783.66
2027 1,101.61 Est @ 4.67% 786.41
2028 1,136.32 Est @ 3.15% 777.72
2029 1,160.06 Est @ 2.09% 761.21
Present value of next 10 years cash flows $6,597.00
DB:VEE DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $1,160.06 × (1 + -0.39%) ÷ (4.3% – -0.39%)
$24,621.35
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $24,621.35 ÷ (1 + 4.3%)10
$16,156.05
DB:VEE Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $6,597.00 + $16,156.05
$22,753.05
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $22,753.05 / 149.26
$152.44
DB:VEE Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:VEE represents 0.92001x of NYSE:VEEV
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.92001x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 152.44 x 0.92001
€140.25
Value per share (EUR) From above. €140.25
Current discount Discount to share price of €141.92
= -1 x (€141.92 - €140.25) / €140.25
-1.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Veeva Systems is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Veeva Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Veeva Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:VEE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2020-01-31) in USD $2.04
NYSE:VEEV Share Price ** NYSE (2020-04-07) in USD $154.26
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.51x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 16.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Veeva Systems.

DB:VEE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:VEEV Share Price ÷ EPS (both in USD)

= 154.26 ÷ 2.04

75.71x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Veeva Systems is overvalued based on earnings compared to the DE Healthcare Services industry average.
  • Veeva Systems is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Veeva Systems's expected growth come at a high price?
Raw Data
DB:VEE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 75.71x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts
13.1%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.68x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

DB:VEE PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 75.71x ÷ 13.1%

5.79x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Veeva Systems is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Veeva Systems's assets?
Raw Data
DB:VEE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2020-01-31) in USD $11.17
NYSE:VEEV Share Price * NYSE (2020-04-07) in USD $154.26
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.82x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.45x
DB:VEE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:VEEV Share Price ÷ Book Value per Share (both in USD)

= 154.26 ÷ 11.17

13.81x

* Primary Listing of Veeva Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Veeva Systems is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Veeva Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Veeva Systems has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

VEE Future Performance

 How is Veeva Systems expected to perform in the next 1 to 3 years based on estimates from 17 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Veeva Systems expected to grow at an attractive rate?
  • Veeva Systems's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Veeva Systems's earnings growth is positive but not above the Germany market average.
  • Veeva Systems's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:VEE Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:VEE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts 13.1%
DB:VEE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 17 Analysts 18.5%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:VEE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:VEE Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-01-31 1,990 797 467 3
2022-01-31 1,660 606 392 16
2021-01-31 1,390 483 308 17
2020-04-07
DB:VEE Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2020-01-31 1,104 437 301
2019-10-31 1,025 430 306
2019-07-31 969 410 288
2019-04-30 911 397 259
2019-01-31 862 311 230
2018-10-31 816 280 199
2018-07-31 768 271 170
2018-04-30 726 242 158
2018-01-31 691 233 151
2017-10-31 655 230 132
2017-07-31 620 223 119
2017-04-30 584 177 93

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Veeva Systems's earnings are expected to grow by 13.1% yearly, however this is not considered high growth (20% yearly).
  • Veeva Systems's revenue is expected to grow by 18.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:VEE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below

All data from Veeva Systems Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:VEE Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-01-31
2022-01-31 2.46 2.86 2.07 8.00
2021-01-31 1.98 2.39 1.72 9.00
2020-04-07
DB:VEE Past Financials Data
Date (Data in USD Millions) EPS *
2020-01-31 2.04
2019-10-31 2.08
2019-07-31 1.97
2019-04-30 1.78
2019-01-31 1.59
2018-10-31 1.39
2018-07-31 1.20
2018-04-30 1.12
2018-01-31 1.08
2017-10-31 0.95
2017-07-31 0.86
2017-04-30 0.68

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Veeva Systems is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Veeva Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Veeva Systems has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

VEE Past Performance

  How has Veeva Systems performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Veeva Systems's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Veeva Systems has delivered over 20% year on year earnings growth in the past 5 years.
  • Veeva Systems's 1-year earnings growth is less than its 5-year average (31% vs 41.5%)
  • Veeva Systems's earnings growth has exceeded the DE Healthcare Services industry average in the past year (31% vs 5.9%).
Earnings and Revenue History
Veeva Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Veeva Systems Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:VEE Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2020-01-31 1,104.08 301.12 303.30 209.90
2019-10-31 1,024.90 306.09 271.04 191.45
2019-07-31 968.71 287.93 257.09 178.88
2019-04-30 911.42 258.97 244.15 166.56
2019-01-31 862.21 229.83 235.28 158.78
2018-10-31 815.87 199.34 224.82 153.02
2018-07-31 768.15 170.18 211.80 147.05
2018-04-30 726.33 158.49 199.71 140.90
2018-01-31 690.56 151.18 189.19 132.02
2017-10-31 654.73 132.23 182.67 121.13
2017-07-31 620.50 118.93 175.45 112.10
2017-04-30 584.05 93.29 170.57 102.99
2017-01-31 550.54 77.57 159.43 96.74
2016-10-31 508.16 64.68 158.91 90.75
2016-07-31 472.30 53.52 149.22 83.40
2016-04-30 439.06 53.95 134.88 75.09
2016-01-31 409.22 54.41 120.24 65.98
2015-10-31 381.96 50.12 104.86 57.62
2015-07-31 358.87 49.85 97.35 50.59
2015-04-30 336.42 45.97 90.88 45.12
2015-01-31 313.22 40.14 86.44 41.16
2014-10-31 289.01 32.64 82.29 37.27
2014-07-31 260.17 24.83 76.47 33.22
2014-04-30 234.08 16.61 69.76 29.79
2014-01-31 210.15 10.41 61.92 26.33
2013-10-31 187.14 5.76 51.61 23.16
2013-07-31 167.95 4.43 42.15 20.18
2013-04-30 147.83 7.24 33.90 17.11

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Veeva Systems has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Veeva Systems used its assets less efficiently than the DE Healthcare Services industry average last year based on Return on Assets.
  • Veeva Systems's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Veeva Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Veeva Systems has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

VEE Health

 How is Veeva Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Veeva Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Veeva Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Veeva Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Veeva Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.1548654612056E+17x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Veeva Systems Company Filings, last reported 2 months ago.

DB:VEE Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2020-01-31 1,665.59 0.00 1,086.75
2019-10-31 1,558.57 0.00 1,494.99
2019-07-31 1,445.02 0.00 1,432.16
2019-04-30 1,335.10 0.00 1,329.65
2019-01-31 1,237.75 0.00 1,090.16
2018-10-31 1,138.31 0.00 1,051.93
2018-07-31 1,050.38 0.00 1,010.43
2018-04-30 974.44 0.00 918.31
2018-01-31 906.24 0.00 761.96
2017-10-31 818.47 0.00 758.08
2017-07-31 766.60 0.00 724.65
2017-04-30 708.90 0.00 663.92
2017-01-31 652.65 0.00 518.87
2016-10-31 605.91 0.00 510.81
2016-07-31 565.11 0.00 479.56
2016-04-30 530.55 0.00 457.44
2016-01-31 505.25 0.00 346.20
2015-10-31 473.98 0.00 339.47
2015-07-31 453.64 0.00 437.97
2015-04-30 428.95 0.00 428.51
2015-01-31 406.83 0.00 397.87
2014-10-31 381.21 0.00 392.87
2014-07-31 357.39 0.00 350.20
2014-04-30 330.29 0.00 345.50
2014-01-31 280.10 0.00 288.13
2013-10-31 270.65 0.00 273.38
2013-07-31 47.40 0.00 52.88
2013-04-30 39.93 0.00 59.20
  • Veeva Systems's level of debt (0%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Veeva Systems's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (6.1555058969412E+18%, greater than 20% of total debt).
  • Veeva Systems earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess Veeva Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Veeva Systems has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

VEE Dividends

 What is Veeva Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Veeva Systems dividends. Estimated to be 0% next year.
If you bought €2,000 of Veeva Systems shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Veeva Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Veeva Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:VEE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 17 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.7%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:VEE Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-01-31
2022-01-31 0.00 1.00
2021-01-31 0.00 1.00
2020-04-07

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Veeva Systems has not reported any payouts.
  • Unable to verify if Veeva Systems's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Veeva Systems's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Veeva Systems has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Veeva Systems's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Veeva Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Veeva Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Veeva Systems has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

VEE Management

 What is the CEO of Veeva Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Peter Gassner
COMPENSATION $322,917
AGE 54
TENURE AS CEO 13.3 years
CEO Bio

Mr. Peter P. Gassner Co-founded Veeva Systems Inc. in 2007 and has been its Chief Executive Officer since January 2007. Mr. Gassner is responsible for the overall direction and management of Verticals on Demand. Mr. Gassner is a twenty year veteran of the software industry. From 2003 to 2005, Mr. Gassner served as Senior Vice President of Technology for salesforce.com where he had responsibility for building the salesforce.com platform including product, marketing and developer relations. From 1995 to 2003, Mr. Gassner served as Chief Architect, Vice President and General Manager of PeopleTools at PeopleSoft. He served as the President of Veeva Systems. Mr. Gassner began his career with IBM in relational database development and research at IBM Silicon Valley Lab and then at IBM Almaden Research Center where he had the privilege of working closely with some of the inventors of relational database technology. He is a technology leader, responsible for creating some of the most widely deployed platforms and solutions in the enterprise software. He was early pioneer in major technology shifts from mainframe to client server and the move to cloud. He has been a Director of Veeva Systems, Inc. since January 2007. He has been an Independent Director of Zoom Video Communications, Inc. since November 2015. He had been a Director of Guidewire Software, Inc. since June 2015 until December 17, 2019 and served as its Chairman since March 2017 until August 05, 2019. Mr. Gassner holds a Bachelor of Science degree in Computer Science from Oregon State University.

CEO Compensation
  • Peter's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Peter's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Veeva Systems management team in years:

5
Average Tenure
50.5
Average Age
  • The average tenure for the Veeva Systems management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Peter Gassner

TITLE
Founder
COMPENSATION
$323K
AGE
54
TENURE
13.3 yrs

Tim Cabral

TITLE
Chief Financial Officer
COMPENSATION
$323K
AGE
52
TENURE
10.2 yrs

Josh Faddis

TITLE
Senior VP
COMPENSATION
$323K
AGE
47
TENURE
7.6 yrs

Eleni Zuppas

TITLE
Chief Marketing Officer
COMPENSATION
$323K
AGE
49
TENURE
7.1 yrs

Alan Mateo

TITLE
Executive Vice President of Global Sales
COMPENSATION
$323K
AGE
57
TENURE
5 yrs

Frederic Lequient

TITLE
Senior Vice President of Global Customer Services
COMPENSATION
$323K
AGE
50
TENURE
4.2 yrs

Tom Schwenger

TITLE
President & COO
AGE
51
TENURE
0.6 yrs

Michele O'Connor

TITLE
Chief Accounting Officer
AGE
42
TENURE
1.1 yrs

Catherine Allshouse

TITLE
Global Chief Information Officer & Head of Operations
TENURE
2.3 yrs

Rick Lund

TITLE
Investor Relations Director
Board of Directors Tenure

Average tenure and age of the Veeva Systems board of directors in years:

4.5
Average Tenure
56
Average Age
  • The tenure for the Veeva Systems board of directors is about average.
Board of Directors

Gordon Ritter

TITLE
Chairman of the Board
COMPENSATION
$325K
AGE
54

Peter Gassner

TITLE
Founder
COMPENSATION
$323K
AGE
54
TENURE
13.3 yrs

Ron Codd

TITLE
Independent Director
COMPENSATION
$312K
AGE
64
TENURE
8.2 yrs

Tim Barabe

TITLE
Independent Director
COMPENSATION
$287K
AGE
66
TENURE
4.6 yrs

Matt Wallach

TITLE
Director
COMPENSATION
$323K
AGE
47
TENURE
0.3 yrs

Paul Sekhri

TITLE
Independent Director
COMPENSATION
$255K
AGE
61
TENURE
5.8 yrs

Paul Chamberlain

TITLE
Independent Director
COMPENSATION
$275K
AGE
55
TENURE
4.3 yrs

Mark Carges

TITLE
Independent Director
COMPENSATION
$250K
AGE
57
TENURE
2.8 yrs

Mary Hedley

TITLE
Director
AGE
56
TENURE
0.7 yrs
Who owns this company?
Recent Insider Trading
  • Veeva Systems individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
01. Apr 20 Sell Eleni Zuppas Individual 30. Mar 20 30. Mar 20 -4,087 €139.37 €-569,608
30. Mar 20 Sell Paul Sekhri Individual 27. Mar 20 27. Mar 20 -1,854 €131.23 €-243,294
13. Jan 20 Sell Michele O'Connor Individual 10. Jan 20 10. Jan 20 -99 €131.41 €-13,010
10. Dec 19 Sell Michele O'Connor Individual 09. Dec 19 09. Dec 19 -217 €129.17 €-28,029
09. Dec 19 Sell Paul Sekhri Individual 06. Dec 19 06. Dec 19 -4,615 €132.23 €-610,229
08. Oct 19 Sell Paul Sekhri Individual 04. Oct 19 04. Oct 19 -628 €137.56 €-86,388
03. Sep 19 Sell Timothy Cabral Individual 29. Aug 19 29. Aug 19 -15,000 €151.50 €-2,272,566
19. Jun 19 Sell Timothy Barabe Individual 18. Jun 19 18. Jun 19 -727 €149.25 €-108,507
X
Management checks
We assess Veeva Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Veeva Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

VEE News

Simply Wall St News

VEE Company Info

Description

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.

Details
Name: Veeva Systems Inc.
VEE
Exchange: DB
Founded: 2007
$21,642,524,954
149,256,521
Website: http://www.veeva.com
Address: Veeva Systems Inc.
4280 Hacienda Drive,
Pleasanton,
California, 94588,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE VEEV Class A Common Stock New York Stock Exchange US USD 16. Oct 2013
DB VEE Class A Common Stock Deutsche Boerse AG DE EUR 16. Oct 2013
LSE 0LO3 Class A Common Stock London Stock Exchange GB USD 16. Oct 2013
BRSE VEE Class A Common Stock Berne Stock Exchange CH CHF 16. Oct 2013
BMV VEEV * Class A Common Stock Bolsa Mexicana de Valores MX MXN 16. Oct 2013
Number of employees
Current staff
Staff numbers
3,501
Veeva Systems employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 22:09
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/04/03
Last earnings filing: 2020/03/30
Last earnings reported: 2020/01/31
Last annual earnings reported: 2020/01/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.